The ALG6 gene helps cells add sugar tags to newly made proteins so they can fold properly and do their jobs. This gene plays an important role in many organs, so if both copies do not work well, a person can develop ALG6-CDG, a rare inherited condition that may cause developmental delay, low muscle tone, seizures, balance problems, and liver or eye issues. Symptoms can vary widely from person to person.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes carry the directions for building proteins, the cell parts that do the work. Other genes are involved mainly in controlling when certain processes happen, where they occur, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more closely, you can find more in the LearnHub.
Overview
ALG6Gene function
What if the gene works
The ALG6 gene helps cells add part of a sugar chain to newly made proteins. This step helps many proteins take the right shape and work normally.
Risk
What if the gene does not work
Pathogenic variants in the ALG6 gene cause ALG6-CDG, often with developmental delay, low muscle tone, poor coordination, and sometimes seizures. Effects can range from mild to more severe, influencing when symptoms appear and which body systems are involved.
Treatment
What does that mean for your treatment
No ALG6-specific treatment or drug choice is currently established in clinical guidelines, so care is guided by a person’s symptoms rather than a gene targeted therapy. The ALG6 gene is being studied in broader congenital disorders of glycosylation research, but this has not yet changed routine treatment.
Conditions associated with ALG6
Gene function
What if the gene works
Many proteins need a small sugar tag before they can take their final shape and move to the right place in the cell. The ALG6 gene helps with an early step in that process inside the cell's protein preparation area, called the endoplasmic reticulum. This supports normal protein folding and steady day-to-day cell function.
The ALG6 gene helps your cells add the first glucose unit to a growing sugar chain prepared for many proteins. This sets up an important early stage of protein sugar tagging in the cell.
Once this sugar chain is attached, it helps many new proteins fold into the right shape. It also helps the cell's folding helpers recognize proteins that are ready to keep moving through the process.
By supporting sugar tagging and folding, the ALG6 gene helps many proteins mature in a controlled way. This keeps routine cell activity more stable across different tissues.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not cause any noticeable changes and are simply part of natural genetic variation. At times, though, a variant can affect how a gene works to a greater extent and may play a part in, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALG6 gene can change the shape or stability of its enzyme, lowering how well cells attach a specific sugar during protein processing. This helps explain how ALG6 gene variants affect protein glycosylation (the cell’s sugar-tagging step). Milder variants may leave some enzyme activity, while more severe variants can nearly stop it. In people with two disease-causing variants, that difference can influence how early ALG6-CDG starts and how strongly it affects the body.
How variants are linked to conditions
Pathogenic variants in the ALG6 gene cause ALG6-CDG, a congenital disorder of glycosylation that can affect development, muscle tone, balance, vision, and seizure risk. Some people have a milder course, while others need more support in childhood. The main well-established condition linked to the ALG6 gene is ALG6-CDG, although researchers continue to study possible links in other settings.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct impact on health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-established variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALG6, risk is usually shaped most by genetics, especially whether harmful changes are inherited in both copies of the gene. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change this risk, though family history can affect the chance of a child inheriting the condition.
Inheritance of ALG6 variants
For the best-known ALG6-related condition, variants in the ALG6 gene are inherited in an autosomal recessive pattern. This means a child inherits one altered copy from each parent, and parents are usually healthy carriers. When both parents carry an ALG6 variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. This is the main way how ALG6 variants are inherited in families.
What does my ALG6 result mean for my family?
For families with an ALG6-related condition, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may wish to learn whether the changed ALG6 copy runs in the family, especially if there is a history of similar symptoms or unexplained illness in childhood. Children of someone with an ALG6-related condition are usually carriers unless the other parent also carries an ALG6 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing is the main way to find out about variants in the ALG6 gene. A lab uses a blood or saliva sample to read the gene’s DNA code and look for changes. Results may show no variant, one variant, or two variants, which can help clarify a diagnosis or carrier status.
When should I consider getting a genetic test?
Genetic testing for the ALG6 gene may be worth considering when a baby or child has signs of ALG6-CDG, a rare inherited condition that can cause poor growth, low muscle tone, developmental delay, seizures, or liver and bleeding problems. Testing can also help if there is a family history of this condition or known ALG6 changes in relatives.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it can tell you depends on the condition and the type of variant involved. Many factors, including age, lifestyle, environment, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, moved through the body, or how strongly it acts on its target. This is common and can help explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It focuses on links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the ALG6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or general health are best discussed with your doctor.
History
ALG6 entered the medical literature in the late 1990s, when researchers studying children with unexplained developmental and multisystem symptoms identified variants in the ALG6 gene as a cause of a congenital disorder of glycosylation, now called ALG6-CDG. This was an important period in genetics, because several related genes were being linked to these conditions for the first time. From these first observations, research expanded steadily. Scientists then recognized that ALG6-CDG could look different from one person to another, which helped refine diagnosis and classification. Over time, laboratory methods improved, making it easier to confirm ALG6 gene variants and distinguish them from other glycosylation conditions. This history helped place the ALG6 gene within a broader group of rare inherited conditions that became much better understood through modern genetic testing.